silver sulfadiazine
Trade name: silvadene
Approved
Nov 26, 1973
Silver sulfadiazine, sold under the brand Silvadene among others, is a topical antibiotic used in partial thickness and full thickness burns to prevent infection. Tentative evidence has found other antibiotics to be more effective, and therefore it is no longer generally recommended for second-degree (partial-thickness) burns, but is still widely used to protect third-degree (full-thickness) burns. — Wikipedia
Clinical trial activity
22 trials · 24 clinical orgs · 4 marketing orgs
Earliest trial started Mar 1, 2004 (NCT00156988)
Timeline
1970s
- Nov 26, 1973
King Pharmaceuticals — Earliest FDA Approval
- Nov 26, 1973
King Pharmaceuticals — NDA Secondary Org
- Nov 26, 1973
King Pharmaceuticals — NDA Organization
1980s
- Feb 25, 1982
Dr. Reddy's Laboratories — NDA Secondary Org
- Feb 25, 1982
Dr. Reddy's Laboratories — Marketing Organization
- Dec 23, 1985
Thepharmanetwork Llc — NDA Secondary Org
- Nov 30, 1989
Franklin Pharmaceuticals — NDA Secondary Org
2000s
- Jan 1, 2007
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Cell membraneDISRUPTING AGENT
Cell membrane disrupting agent
Approval history
- approvedPriority reviewNov 26, 1973
Chemistry & pharmacology
SMILES
[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C2=NC=CC=N2- Mol. weight
- 357.137 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Prescription Only
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaSilver sulfadiazine ↗
- NCATSW46JY43EJR ↗
- ChEMBLCHEMBL439 ↗
- ChEMBLCHEMBL1382627 ↗
Also known as
- flamazine
- flamazine
- silvadene
- silvadene
- silvadene
- silvadene
- silver sulfadiazinate
- silver sulfadiazinate
- silver sulfadiazine
- silver sulfadiazine
- silver sulfadiazine
- silver sulfadiazine
- silver sulfadiazine
- silver sulfadiazine
- silver sulfadiazine
- silver sulfadiazine
- silver sulphadiazine
- silver sulphadiazine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05877638 | N/A | Mar 27, 2023 | Louisiana State University, Synedgen |
| NCT05347654 | N/A | Dec 15, 2022 | University of Lyon |
| NCT05073172 | N/A | Dec 31, 2021 | OHSU Knight Cancer Institute, Oregon Health and Science University |
| NCT04601532 | Phase 4 | Feb 28, 2021 | Department of Defense, Synedgen, University of Pittsburgh |
| NCT03162367 | Phase 2 | Nov 10, 2017 | Tabriz Medical University |
| NCT04391582 | Phase 2 | May 1, 2017 | Federal University of Ceara |
| NCT04202289 | Phase 3 | Apr 3, 2017 | Federal University of Ceara |
| NCT03592498 | Phase 2 | Oct 5, 2016 | Federal University of Ceara |
| NCT02116010 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2015 | Pherecydes Pharma |
| NCT02108535 | Phase 4 | Nov 1, 2013 | University of Sorocaba |
| NCT01598493 | N/A | May 1, 2012 | Bio-medical Carbon Technology Co., Ltd., National Taiwan University |
| NCT01598480 | N/A | May 1, 2012 | Bio-medical Carbon Technology Co., Ltd., National Taiwan University |
| NCT01701466 | Phase 2 | Dec 31, 2011 | McGill University |
| NCT01553708 | Phase 2/Phase 3 (Phase 3) | Dec 1, 2011 | Chulalongkorn University, National Science and Technology Development Agency, Thailand |
| NCT01439074 | Phase 4 | Sep 1, 2011 | Molnlycke Health Care AB |
| NCT01926392 | Phase 4 | Apr 1, 2011 | University of Virginia |
| NCT02109718 | Phase 3 | Jan 1, 2009 | University of the Philippines |
| NCT01017094 | Phase 3 | Sep 1, 2007 | Prince of Songkla University |
| NCT00634166 | Phase 4 | Sep 1, 2007 | Mylan |
| NCT00297752 | Phase 4 | Mar 1, 2006 | Association of Dutch Burn Centres, Dutch Burns Foundation |
Organizations
Research & Development (24)
Marketing (6)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Dr. Reddy's Laboratories | For profit | NDA2 | Feb 25, 1982 |
| Dr. Reddy's Laboratories | For profit | MKTG | Feb 25, 1982 |
| Franklin Pharmaceuticals | For profit | NDA2 | Nov 30, 1989 |
| King Pharmaceuticals | For profit | NDA2 | Nov 26, 1973 |
| King Pharmaceuticals | For profit | NDA | Nov 26, 1973 |
| Thepharmanetwork Llc | For profit | NDA2 | Dec 23, 1985 |